The combination treatment with FAAH inhibitors, exemplified by URB597, and ferroptosis inducers has been shown to effectively inhibit the PI3K/Akt pathway in the context of renal cell carcinoma. Here, AKT1 is linked to hereditary clear cell renal cell carcinoma.